lets all stop looking at short term moves and look at the big picture...they developed 1 approved drug and a 2nd on the way that should prove to be "best in class"...obviously time will tell...but will have a much better idea with ponatinib in the EPIC trial and over the next several months to year with ap26113 as more data is released.
Nobody likes to see their stock portfolio go south but only temparary.My belief is that low to mid 18's is good support.
Smart money is buying..scared money is selling!!!!
News 
Market Data 
Discover 
AI
